

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of MHC class I biosynthetic process (GO:0045343) | 9.79395254 |
| 2 | regulation of establishment of cell polarity (GO:2000114) | 9.69703160 |
| 3 | sex differentiation (GO:0007548) | 9.27185609 |
| 4 | regulation of interleukin-13 production (GO:0032656) | 8.62803239 |
| 5 | cholesterol catabolic process (GO:0006707) | 8.17983974 |
| 6 | sterol catabolic process (GO:0016127) | 8.17983974 |
| 7 | stress granule assembly (GO:0034063) | 8.03336086 |
| 8 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 7.80070077 |
| 9 | regulation of interleukin-5 production (GO:0032674) | 7.05234646 |
| 10 | cerebellar Purkinje cell differentiation (GO:0021702) | 6.93163133 |
| 11 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.83246720 |
| 12 | ADP metabolic process (GO:0046031) | 6.70434035 |
| 13 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.44425219 |
| 14 | positive regulation of vasculogenesis (GO:2001214) | 6.26558676 |
| 15 | centrosome duplication (GO:0051298) | 6.16150960 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 5.67781695 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 5.67781695 |
| 18 | tryptophan catabolic process (GO:0006569) | 5.67781695 |
| 19 | nucleoside diphosphate catabolic process (GO:0009134) | 5.62648174 |
| 20 | regulation of metalloenzyme activity (GO:0048552) | 5.58937324 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.58747848 |
| 22 | seminiferous tubule development (GO:0072520) | 5.08211892 |
| 23 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 5.03598382 |
| 24 | acrosome assembly (GO:0001675) | 5.02221729 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.87996673 |
| 26 | regulation of vasculogenesis (GO:2001212) | 4.81716988 |
| 27 | tryptophan metabolic process (GO:0006568) | 4.68179121 |
| 28 | lipid particle organization (GO:0034389) | 4.66457830 |
| 29 | sperm motility (GO:0030317) | 4.38714595 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.20142824 |
| 31 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.19006722 |
| 32 | positive regulation of heat generation (GO:0031652) | 4.14706789 |
| 33 | regulation of type 2 immune response (GO:0002828) | 4.11035132 |
| 34 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 4.06407425 |
| 35 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 4.04347603 |
| 36 | one-carbon compound transport (GO:0019755) | 4.03928022 |
| 37 | regulation of action potential (GO:0098900) | 4.01274923 |
| 38 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.99291021 |
| 39 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.99291021 |
| 40 | protein autoprocessing (GO:0016540) | 3.98845676 |
| 41 | microtubule polymerization or depolymerization (GO:0031109) | 3.91483886 |
| 42 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.87720955 |
| 43 | synaptic transmission, cholinergic (GO:0007271) | 3.85932264 |
| 44 | establishment of protein localization to Golgi (GO:0072600) | 3.71260109 |
| 45 | NAD biosynthetic process (GO:0009435) | 3.70461392 |
| 46 | negative regulation of T cell differentiation (GO:0045581) | 3.70166015 |
| 47 | estrogen biosynthetic process (GO:0006703) | 3.67951383 |
| 48 | negative regulation of mast cell activation (GO:0033004) | 3.67169226 |
| 49 | regulation of superoxide metabolic process (GO:0090322) | 3.67132067 |
| 50 | lipid translocation (GO:0034204) | 3.61782779 |
| 51 | phospholipid translocation (GO:0045332) | 3.61782779 |
| 52 | steroid catabolic process (GO:0006706) | 3.60336436 |
| 53 | histone H3-K4 trimethylation (GO:0080182) | 3.57917880 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.52701361 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.52011034 |
| 56 | amine catabolic process (GO:0009310) | 3.52011034 |
| 57 | somite rostral/caudal axis specification (GO:0032525) | 3.48558728 |
| 58 | protein targeting to Golgi (GO:0000042) | 3.45730803 |
| 59 | regulation of sequestering of triglyceride (GO:0010889) | 3.42442332 |
| 60 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.40191312 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.38857475 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 3.33821577 |
| 63 | aromatic amino acid family catabolic process (GO:0009074) | 3.32469348 |
| 64 | cell differentiation in hindbrain (GO:0021533) | 3.32010339 |
| 65 | regulation of response to reactive oxygen species (GO:1901031) | 3.27702953 |
| 66 | negative regulation of endothelial cell migration (GO:0010596) | 3.23474790 |
| 67 | response to X-ray (GO:0010165) | 3.21833634 |
| 68 | multicellular organism reproduction (GO:0032504) | 3.21065323 |
| 69 | axonemal dynein complex assembly (GO:0070286) | 3.20204366 |
| 70 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.19915550 |
| 71 | regulation of receptor internalization (GO:0002090) | 3.16705311 |
| 72 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.15496984 |
| 73 | male meiosis I (GO:0007141) | 3.13915678 |
| 74 | response to lipoprotein particle (GO:0055094) | 3.13249850 |
| 75 | regulation of heat generation (GO:0031650) | 3.13174449 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10312798 |
| 77 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.10076890 |
| 78 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.08493059 |
| 79 | iron ion import (GO:0097286) | 3.04597782 |
| 80 | acrosome reaction (GO:0007340) | 3.03940100 |
| 81 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.01102764 |
| 82 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.01102764 |
| 83 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.95289480 |
| 84 | ketone body metabolic process (GO:1902224) | 2.94341056 |
| 85 | JAK-STAT cascade (GO:0007259) | 2.94288198 |
| 86 | androgen biosynthetic process (GO:0006702) | 2.92326054 |
| 87 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.91278721 |
| 88 | actin cytoskeleton reorganization (GO:0031532) | 2.90731296 |
| 89 | sperm-egg recognition (GO:0035036) | 2.87144020 |
| 90 | regulation of ARF GTPase activity (GO:0032312) | 2.87139034 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.85728870 |
| 92 | neuronal action potential propagation (GO:0019227) | 2.85644181 |
| 93 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.83200505 |
| 94 | DNA replication checkpoint (GO:0000076) | 2.81140195 |
| 95 | regulation of histone H3-K9 methylation (GO:0051570) | 2.80266414 |
| 96 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.79999010 |
| 97 | regulation of memory T cell differentiation (GO:0043380) | 12.3762068 |
| 98 | cytoplasmic mRNA processing body assembly (GO:0033962) | 10.9367377 |
| 99 | negative regulation of multicellular organism growth (GO:0040015) | 10.9044876 |
| 100 | negative regulation of type 2 immune response (GO:0002829) | 10.3685647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.29906022 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.50410518 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.36142791 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.08371569 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.95841068 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.99918211 |
| 7 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.75191476 |
| 8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.74827424 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.33273586 |
| 10 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.31445485 |
| 11 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.25929926 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24675772 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18057817 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13895355 |
| 15 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 2.08555042 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99886893 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97743967 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.96818115 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91043272 |
| 20 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.74106685 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71306363 |
| 22 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.67583977 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.57567317 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57526986 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56381668 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54866450 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54866450 |
| 28 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.49341716 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48095707 |
| 30 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.46722592 |
| 31 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.43815237 |
| 32 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.41001993 |
| 33 | ERA_21632823_ChIP-Seq_H3396_Human | 1.40716618 |
| 34 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.39738068 |
| 35 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34889552 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34889552 |
| 37 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33264407 |
| 38 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.32641809 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31468256 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29176093 |
| 41 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27315625 |
| 42 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.25691108 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25415171 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23875387 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23456539 |
| 46 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23129248 |
| 47 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.22444753 |
| 48 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.21376387 |
| 49 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.21274475 |
| 50 | * NFYB_21822215_ChIP-Seq_K562_Human | 1.20902285 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20436509 |
| 52 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19880155 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.17854890 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17777270 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17091228 |
| 56 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16997789 |
| 57 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.16882054 |
| 58 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16356283 |
| 59 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15442765 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14833942 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.14433173 |
| 62 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14147903 |
| 63 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.13349425 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12408497 |
| 65 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.11284625 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11142407 |
| 67 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10365951 |
| 68 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08992254 |
| 69 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.07719884 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06514817 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05694160 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05270955 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04624756 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03751739 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03017545 |
| 76 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.02745237 |
| 77 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02590134 |
| 78 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01846412 |
| 79 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 1.00788915 |
| 80 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.00097529 |
| 81 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98386478 |
| 82 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98351170 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.98252221 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97762660 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97731450 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97333079 |
| 87 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96845002 |
| 88 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96769301 |
| 89 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96769301 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 0.94106431 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93372828 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93320881 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92912126 |
| 94 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.92368537 |
| 95 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90749140 |
| 96 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89415394 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88218206 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87828659 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87396763 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87301733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003252_abnormal_bile_duct | 6.60581761 |
| 2 | MP0003011_delayed_dark_adaptation | 6.54367255 |
| 3 | MP0005410_abnormal_fertilization | 5.40945176 |
| 4 | MP0002736_abnormal_nociception_after | 4.13876245 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.75707287 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.50727785 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.14248813 |
| 8 | MP0000371_diluted_coat_color | 2.94363054 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.62946227 |
| 10 | MP0005253_abnormal_eye_physiology | 2.29445572 |
| 11 | MP0003718_maternal_effect | 2.11450161 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.10233101 |
| 13 | MP0003646_muscle_fatigue | 2.00737562 |
| 14 | MP0005647_abnormal_sex_gland | 2.00487804 |
| 15 | MP0003172_abnormal_lysosome_physiology | 1.99840005 |
| 16 | MP0005083_abnormal_biliary_tract | 1.98651584 |
| 17 | MP0009840_abnormal_foam_cell | 1.93574244 |
| 18 | MP0005310_abnormal_salivary_gland | 1.93457581 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 1.88382759 |
| 20 | MP0001348_abnormal_lacrimal_gland | 1.78047722 |
| 21 | MP0009745_abnormal_behavioral_response | 1.75927676 |
| 22 | MP0003698_abnormal_male_reproductive | 1.75375468 |
| 23 | MP0005334_abnormal_fat_pad | 1.58028326 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 1.57928515 |
| 25 | MP0003878_abnormal_ear_physiology | 1.57928515 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 1.54739880 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.52398473 |
| 28 | MP0003186_abnormal_redox_activity | 1.49511546 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.45650588 |
| 30 | MP0002161_abnormal_fertility/fecundity | 1.40923924 |
| 31 | MP0001929_abnormal_gametogenesis | 1.38592033 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.38510243 |
| 33 | MP0009697_abnormal_copulation | 1.35766484 |
| 34 | MP0004233_abnormal_muscle_weight | 1.34511097 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.33123729 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.32194192 |
| 37 | MP0001486_abnormal_startle_reflex | 1.28747679 |
| 38 | MP0004130_abnormal_muscle_cell | 1.28249254 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.23044134 |
| 40 | MP0003195_calcinosis | 1.22561843 |
| 41 | MP0003137_abnormal_impulse_conducting | 1.20561679 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.20109198 |
| 43 | MP0000653_abnormal_sex_gland | 1.15945543 |
| 44 | MP0002282_abnormal_trachea_morphology | 1.15351071 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.14591483 |
| 46 | MP0009046_muscle_twitch | 1.14369772 |
| 47 | MP0004147_increased_porphyrin_level | 1.13563572 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.13055818 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.07593340 |
| 50 | MP0002210_abnormal_sex_determination | 1.05538297 |
| 51 | MP0001145_abnormal_male_reproductive | 1.01776747 |
| 52 | MP0002132_abnormal_respiratory_system | 1.01121465 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.00952393 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.00930115 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.00770094 |
| 56 | MP0001764_abnormal_homeostasis | 0.98825240 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 0.95630389 |
| 58 | MP0002075_abnormal_coat/hair_pigmentati | 0.93601828 |
| 59 | MP0008961_abnormal_basal_metabolism | 0.90662437 |
| 60 | MP0000427_abnormal_hair_cycle | 0.87278131 |
| 61 | MP0005670_abnormal_white_adipose | 0.85252894 |
| 62 | MP0005171_absent_coat_pigmentation | 0.85051355 |
| 63 | MP0002064_seizures | 0.84614491 |
| 64 | MP0001873_stomach_inflammation | 0.84023241 |
| 65 | MP0004742_abnormal_vestibular_system | 0.82499504 |
| 66 | MP0005451_abnormal_body_composition | 0.82135834 |
| 67 | MP0003936_abnormal_reproductive_system | 0.81671912 |
| 68 | MP0000609_abnormal_liver_physiology | 0.81048933 |
| 69 | MP0009115_abnormal_fat_cell | 0.79472538 |
| 70 | MP0005395_other_phenotype | 0.77869472 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.76754869 |
| 72 | MP0002733_abnormal_thermal_nociception | 0.75687919 |
| 73 | MP0002272_abnormal_nervous_system | 0.75442901 |
| 74 | MP0008770_decreased_survivor_rate | 0.72620691 |
| 75 | MP0002229_neurodegeneration | 0.70524960 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.70451920 |
| 77 | MP0001730_embryonic_growth_arrest | 0.70054954 |
| 78 | MP0003935_abnormal_craniofacial_develop | 0.69829494 |
| 79 | MP0005391_vision/eye_phenotype | 0.68908880 |
| 80 | MP0005408_hypopigmentation | 0.67986341 |
| 81 | MP0003119_abnormal_digestive_system | 0.65280698 |
| 82 | MP0004510_myositis | 0.64252020 |
| 83 | MP0000749_muscle_degeneration | 0.63160586 |
| 84 | MP0008004_abnormal_stomach_pH | 0.59040428 |
| 85 | MP0001944_abnormal_pancreas_morphology | 0.56648068 |
| 86 | MP0005360_urolithiasis | 0.56515638 |
| 87 | MP0003699_abnormal_female_reproductive | 0.56389084 |
| 88 | MP0002234_abnormal_pharynx_morphology | 0.55155176 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.53409729 |
| 90 | MP0000685_abnormal_immune_system | 0.53268983 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.52352584 |
| 92 | MP0000470_abnormal_stomach_morphology | 0.52052883 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.51897444 |
| 94 | MP0001186_pigmentation_phenotype | 0.51216401 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.46961799 |
| 96 | MP0003633_abnormal_nervous_system | 0.46296045 |
| 97 | MP0004043_abnormal_pH_regulation | 0.46267382 |
| 98 | MP0001664_abnormal_digestion | 0.46246931 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.46062000 |
| 100 | MP0004381_abnormal_hair_follicle | 0.45602135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 9.56544162 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 8.82395240 |
| 3 | Prostate neoplasm (HP:0100787) | 7.46991489 |
| 4 | Abnormality of the hepatic vasculature (HP:0006707) | 6.11595526 |
| 5 | Postural instability (HP:0002172) | 6.10503852 |
| 6 | Slow saccadic eye movements (HP:0000514) | 5.87832696 |
| 7 | Absence seizures (HP:0002121) | 5.72456882 |
| 8 | Pendular nystagmus (HP:0012043) | 5.38443080 |
| 9 | Urinary bladder sphincter dysfunction (HP:0002839) | 5.24952990 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 5.23812040 |
| 11 | Severe visual impairment (HP:0001141) | 5.16507703 |
| 12 | Postural tremor (HP:0002174) | 4.89567869 |
| 13 | Dysdiadochokinesis (HP:0002075) | 4.46230504 |
| 14 | Limb ataxia (HP:0002070) | 4.45008180 |
| 15 | Impaired vibratory sensation (HP:0002495) | 4.40503032 |
| 16 | Dialeptic seizures (HP:0011146) | 4.30418730 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.94244737 |
| 18 | Abnormality of macular pigmentation (HP:0008002) | 3.91282323 |
| 19 | Abnormality of the prostate (HP:0008775) | 3.89840203 |
| 20 | Focal seizures (HP:0007359) | 3.80926334 |
| 21 | Impaired smooth pursuit (HP:0007772) | 3.75609217 |
| 22 | Impaired proprioception (HP:0010831) | 3.58289606 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.41184445 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 3.41184445 |
| 25 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.98733304 |
| 26 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.98528881 |
| 27 | Abnormality of saccadic eye movements (HP:0000570) | 2.77160695 |
| 28 | Postnatal microcephaly (HP:0005484) | 2.71110050 |
| 29 | Abnormality of male internal genitalia (HP:0000022) | 2.67704076 |
| 30 | Hyperthyroidism (HP:0000836) | 2.65542329 |
| 31 | Abnormal ciliary motility (HP:0012262) | 2.65434010 |
| 32 | Atonic seizures (HP:0010819) | 2.63549918 |
| 33 | Tinnitus (HP:0000360) | 2.60867585 |
| 34 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.58405613 |
| 35 | Portal hypertension (HP:0001409) | 2.51507353 |
| 36 | Bradykinesia (HP:0002067) | 2.43209653 |
| 37 | Abnormality of vision evoked potentials (HP:0000649) | 2.40162283 |
| 38 | Truncus arteriosus (HP:0001660) | 2.36152932 |
| 39 | Hypochromic anemia (HP:0001931) | 2.35237706 |
| 40 | Areflexia of lower limbs (HP:0002522) | 2.34059071 |
| 41 | Oculomotor apraxia (HP:0000657) | 2.24456843 |
| 42 | Increased corneal curvature (HP:0100692) | 2.23697702 |
| 43 | Keratoconus (HP:0000563) | 2.23697702 |
| 44 | Chorioretinal atrophy (HP:0000533) | 2.22791918 |
| 45 | Focal motor seizures (HP:0011153) | 2.22107298 |
| 46 | Rib fusion (HP:0000902) | 2.19733825 |
| 47 | Vitreoretinal degeneration (HP:0000655) | 2.18215039 |
| 48 | Chronic hepatic failure (HP:0100626) | 2.17026269 |
| 49 | Severe Myopia (HP:0011003) | 2.13500816 |
| 50 | Clumsiness (HP:0002312) | 2.07245103 |
| 51 | Gingival bleeding (HP:0000225) | 2.03219009 |
| 52 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.01468932 |
| 53 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.01468932 |
| 54 | Retinitis pigmentosa (HP:0000510) | 2.00924491 |
| 55 | Genetic anticipation (HP:0003743) | 10.9412633 |
| 56 | Dysmetric saccades (HP:0000641) | 10.6676432 |
| 57 | Biliary tract neoplasm (HP:0100574) | 1.98020549 |
| 58 | Male infertility (HP:0003251) | 1.93341911 |
| 59 | Infertility (HP:0000789) | 1.85491129 |
| 60 | Febrile seizures (HP:0002373) | 1.82403675 |
| 61 | Amaurosis fugax (HP:0100576) | 1.82121926 |
| 62 | Arterial thrombosis (HP:0004420) | 1.81813186 |
| 63 | Bilateral microphthalmos (HP:0007633) | 1.81501203 |
| 64 | Hypophosphatemic rickets (HP:0004912) | 1.79500667 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 1.78903800 |
| 66 | Protruding tongue (HP:0010808) | 1.77991094 |
| 67 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.76785689 |
| 68 | Hyperventilation (HP:0002883) | 1.72304977 |
| 69 | Attenuation of retinal blood vessels (HP:0007843) | 1.71467790 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.71426055 |
| 71 | Chromsome breakage (HP:0040012) | 1.70876981 |
| 72 | Loss of speech (HP:0002371) | 1.68752346 |
| 73 | Rhinitis (HP:0012384) | 1.66663598 |
| 74 | Anomalous pulmonary venous return (HP:0010772) | 1.63796163 |
| 75 | Fasciculations (HP:0002380) | 1.61255405 |
| 76 | Ileus (HP:0002595) | 1.61188560 |
| 77 | Dysmetria (HP:0001310) | 1.58335373 |
| 78 | Tubulointerstitial nephritis (HP:0001970) | 1.57728349 |
| 79 | Proximal tubulopathy (HP:0000114) | 1.55516379 |
| 80 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.55171909 |
| 81 | Progressive hearing impairment (HP:0001730) | 1.54839825 |
| 82 | Cortical visual impairment (HP:0100704) | 1.53551558 |
| 83 | Decreased muscle mass (HP:0003199) | 1.50714457 |
| 84 | Seborrheic dermatitis (HP:0001051) | 1.50563823 |
| 85 | Abnormal EKG (HP:0003115) | 1.49340100 |
| 86 | Hypertensive crisis (HP:0100735) | 1.47874892 |
| 87 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.46521360 |
| 88 | Pancreatic cysts (HP:0001737) | 1.46131709 |
| 89 | Progressive sensorineural hearing impairment (HP:0000408) | 1.45347914 |
| 90 | Horizontal nystagmus (HP:0000666) | 1.44970334 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 1.43864601 |
| 92 | Macular degeneration (HP:0000608) | 1.42677969 |
| 93 | Rigidity (HP:0002063) | 1.40897483 |
| 94 | Bowel incontinence (HP:0002607) | 1.40543210 |
| 95 | Macroglossia (HP:0000158) | 1.39098850 |
| 96 | Hypoproteinemia (HP:0003075) | 1.39095518 |
| 97 | Atelectasis (HP:0100750) | 1.39093257 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.39015509 |
| 99 | Obstructive lung disease (HP:0006536) | 1.39015509 |
| 100 | Generalized aminoaciduria (HP:0002909) | 1.38370285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 5.57276518 |
| 2 | FRK | 5.39682502 |
| 3 | PINK1 | 2.88353611 |
| 4 | PLK4 | 2.79401979 |
| 5 | BRD4 | 2.44557694 |
| 6 | MAP3K7 | 2.39538882 |
| 7 | TNK2 | 2.29275821 |
| 8 | ACVR1B | 2.17706220 |
| 9 | CDK19 | 10.9862845 |
| 10 | CDK12 | 1.97535176 |
| 11 | GRK1 | 1.96071630 |
| 12 | BMPR1B | 1.91809181 |
| 13 | TXK | 1.62264030 |
| 14 | MKNK2 | 1.60735387 |
| 15 | INSRR | 1.56354467 |
| 16 | STK38 | 1.52470073 |
| 17 | ALK | 1.31992803 |
| 18 | ZAK | 1.31569909 |
| 19 | RPS6KB2 | 1.24648086 |
| 20 | STK3 | 1.11600405 |
| 21 | ADRBK2 | 1.10419105 |
| 22 | MARK3 | 1.08634329 |
| 23 | PDPK1 | 1.08474026 |
| 24 | PDK1 | 1.04357214 |
| 25 | MKNK1 | 0.92481467 |
| 26 | FER | 0.86037308 |
| 27 | PLK2 | 0.84068040 |
| 28 | PIK3CG | 0.82794157 |
| 29 | TAOK3 | 0.79709172 |
| 30 | JAK2 | 0.78368132 |
| 31 | TGFBR1 | 0.76503341 |
| 32 | MAP3K9 | 0.75697133 |
| 33 | RIPK4 | 0.74029382 |
| 34 | KSR2 | 0.73333024 |
| 35 | BCR | 0.72362660 |
| 36 | MTOR | 0.67499528 |
| 37 | STK38L | 0.67481536 |
| 38 | STK11 | 0.66062035 |
| 39 | TYRO3 | 0.61505425 |
| 40 | NTRK3 | 0.60735220 |
| 41 | CHEK1 | 0.50122102 |
| 42 | PRKAA2 | 0.49438628 |
| 43 | MAPKAPK5 | 0.49005949 |
| 44 | PDK2 | 0.47451325 |
| 45 | CHEK2 | 0.47013631 |
| 46 | WNK1 | 0.44774948 |
| 47 | TIE1 | 0.43619755 |
| 48 | BLK | 0.43512595 |
| 49 | CDK9 | 0.42955142 |
| 50 | MAP4K2 | 0.42854754 |
| 51 | PBK | 0.40678642 |
| 52 | WNK4 | 0.40509599 |
| 53 | PTK2B | 0.38984596 |
| 54 | MAP2K1 | 0.38886790 |
| 55 | MST1R | 0.36991015 |
| 56 | BRSK2 | 0.36055715 |
| 57 | DDR2 | 0.35051718 |
| 58 | NEK6 | 0.33928079 |
| 59 | JAK3 | 0.32169725 |
| 60 | CDK15 | 0.31554798 |
| 61 | PRKG1 | 0.31049667 |
| 62 | EEF2K | 0.29815492 |
| 63 | TRPM7 | 0.29264128 |
| 64 | CDK14 | 0.28480715 |
| 65 | CDK11A | 0.27650014 |
| 66 | MAP3K2 | 0.27325891 |
| 67 | CDK18 | 0.26972618 |
| 68 | CDK4 | 0.26859340 |
| 69 | MAPK1 | 0.25450038 |
| 70 | PAK1 | 0.25353303 |
| 71 | MAPK11 | 0.24630641 |
| 72 | NEK2 | 0.24009475 |
| 73 | MATK | 0.23605679 |
| 74 | RPS6KA5 | 0.23079912 |
| 75 | PRKG2 | 0.22411097 |
| 76 | SIK2 | 0.22357061 |
| 77 | PRKAA1 | 0.19762526 |
| 78 | CDK5 | 0.19384696 |
| 79 | BMX | 0.19130204 |
| 80 | MAP3K8 | 0.18675352 |
| 81 | MAP2K6 | 0.17336751 |
| 82 | AKT1 | 0.17289313 |
| 83 | SGK1 | 0.16421839 |
| 84 | CSNK1A1 | 0.16345514 |
| 85 | MAPK15 | 0.16149796 |
| 86 | TTK | 0.15889150 |
| 87 | BMPR2 | 0.15759127 |
| 88 | BTK | 0.15440110 |
| 89 | CLK1 | 0.13633148 |
| 90 | CDK1 | 0.13494550 |
| 91 | IRAK3 | 0.13137285 |
| 92 | TEC | 0.12656431 |
| 93 | RPS6KA1 | 0.11810718 |
| 94 | GSK3B | 0.10277296 |
| 95 | STK4 | 0.10176439 |
| 96 | FGR | 0.09936371 |
| 97 | CSNK1A1L | 0.09439990 |
| 98 | GRK7 | 0.09411782 |
| 99 | MARK2 | 0.09324595 |
| 100 | MAP3K4 | 0.08479916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 8.84723061 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.86235712 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.51450855 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.09506082 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.99149164 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.35864955 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30308852 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.11824296 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.08748132 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02171451 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 1.96249185 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86290895 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81627440 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70320745 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.51594532 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44892500 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39419924 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36452392 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32211626 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19573254 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16268633 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13942198 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13448107 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.12711591 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08565105 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.03530260 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98474862 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98043775 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96024095 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88391711 |
| 31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88279143 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85900536 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84883399 |
| 34 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.81136284 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 0.80888853 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79868962 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79237321 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76020925 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75519691 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74063529 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72226025 |
| 42 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72177596 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68810047 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68506911 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68175976 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.67473432 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65222411 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.64525194 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64300007 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60481645 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59831197 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58874390 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53428723 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.50505585 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49417418 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48733986 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46636101 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.46389930 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44290174 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43162610 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43150148 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40415400 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.39499398 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39092981 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38039518 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37778675 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35862086 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.35062580 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34971084 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.34149904 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.33715079 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33232702 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33209924 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.33203788 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32635844 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32033341 |
| 77 | Melanoma_Homo sapiens_hsa05218 | 0.31331982 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30371640 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29930558 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29775449 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29576361 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28471516 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28019503 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27072715 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26742930 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.26520680 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.25979043 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.25855850 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.24931702 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.24575987 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23923666 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.23766748 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23459096 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23009256 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.22811854 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21334049 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21316312 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.18205072 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18112159 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17514508 |

